Immune Senescence and Vaccination in the Elderly

  • Pierre Olivier Lang
  • , Sheila Govind
  • , Annemieke Ten Bokum
  • , Natalie Kenny
  • , Emmanuel Matas
  • , David Pitts
  • , Richard Aspinall

    Research output: Contribution to journalReview articlepeer-review

    Abstract

    Vaccines are powerful public health tools that have been of tremendous benefit in protecting vulnerable populations worldwide from many pathogens. However, vaccine- preventable diseases still remain a considerable burden and this is particularly true among aging and aged populations in industrialized countries. The predicted demographic shift in the population landscape towards an ever-increasing aging population and the evidence suggesting that older individuals mount less-than optimal immune response to vaccination have raised the question of improving vaccine responses in older individuals. This review presents recent progress in the understanding at the cellular and molecular levels of age related immune decline and strategies to translate current knowledge into the development of immunization strategies to promote healthy aging, keeping older members of our society autonomous and independent.

    Original languageEnglish
    Pages (from-to)2541-2550
    Number of pages10
    JournalCurrent Topics in Medicinal Chemistry
    Volume13
    Issue number20
    Publication statusPublished - 1 Oct 2013

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Healthy aging
    • vaccine effectiveness
    • vaccine development
    • vaccine design
    • vaccination
    • older adults
    • immunosenescence

    ASJC Scopus subject areas

    • Drug Discovery

    Fingerprint

    Dive into the research topics of 'Immune Senescence and Vaccination in the Elderly'. Together they form a unique fingerprint.

    Cite this